Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PLAT | P00750 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18975305 | 0.86 | MEN1 (0.38) | HSD17B10L3MBTL1KDM4ESMN1; SMN2 | |
| SCHEMBL16228133 | 0.84 | HSD17B10 (0.50) | HSD17B10SMN1; SMN2TSHRITGB3ITGA2B | |
| SCHEMBL21675522 | 0.83 | SMN1; SMN2 (0.42) | HSD17B10L3MBTL1KDM4ESMN1; SMN2LMNA | |
| SCHEMBL14621507 | 0.83 | HSD17B10 (0.45) | HSD17B10KDM4ESMN1; SMN2ITGB3ITGA2B | |
| SCHEMBL9912438 | 0.83 | KDM4E (0.50) | L3MBTL1KDM4ESMN1; SMN2LMNATSHR | |
| SCHEMBL7765808 | 0.83 | SMN1; SMN2 (0.62) | HSD17B10KDM4ESMN1; SMN2 | |
| SCHEMBL19514340 | 0.81 | LTA4H (0.47) | L3MBTL1KDM4ESMN1; SMN2LMNATSHR | |
| Water SCHEMBL28581624 | 0.81 | SMN1; SMN2 (0.60) | HSD17B10KDM4ESMN1; SMN2 | |
| SCHEMBL23291292 | 0.79 | HSD17B10 (0.56) | HSD17B10KDM4ETSHRITGB3ITGA2B | |
| SCHEMBL9839122 | 0.79 | L3MBTL1 (0.44) | L3MBTL1KDM4ESMN1; SMN2LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | claimed |
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
| CN-119977991-A | Medicine for treating severe malaria and synthesis method thereof | 中国中医科学院中药研究所 | 2025-05-13 | — | — | CN | disclosed |
| CN-116077553-B | Dressing containing walnut shell extract for promoting wound healing and preparation method thereof | 西安交通大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-116077553-A | Application of walnut shell extract in promoting wound healing, wound dressing based on walnut shell extract and preparation method of wound dressing | 西安交通大学 | 2023-05-09 | — | — | CN | disclosed |
| US-10689430-B2 | Insulin receptor partial agonists | MERCK SHARP & DOHME CORP. (US) | 2020-06-23 | — | — | US | disclosed |
| US-20190177393-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2019-06-13 | — | — | US | disclosed |
| EP-1870396-B1 | BENZYLOXYPROPYLAMINE DERIVATIVE | NIPPON ZOKI PHARMACEUTICAL CO (JP) | 2012-10-31 | — | — | EP | disclosed |
| US-7939552-B2 | Tachykinin receptor anatgonist; good transfer into blood; long half-life; stability; bradycardial agents; antiinflammatory agents ; antallergens; analgesics; antiemetics; irritable bowel disorders; skin disorders; antidepressants; antiischemic agents ; anxiolytic agents; autoimmune diseases; muscle relax | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2011-05-10 | — | — | US | disclosed |
| US-20080262230-A1 | Benzyloxypropylamine Derivative | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| EP-1870396-A1 | BENZYLOXYPROPYLAMINE DERIVATIVE | Nippon Zoki Pharmaceutical Co. Ltd. (JP) | 2007-12-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | HSD17B10 4316/4885L3MBTL1 1947/4885KDM4E 4163/4885 |
| US-20190177393-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | INSR, GPR119, IRS1 | HSD17B10 2172/4885L3MBTL1 3741/4885KDM4E 4815/4885 |
| US-10689430-B2 | Insulin receptor partial agonists | INSR, GPR119, IRS1 | HSD17B10 2172/4885L3MBTL1 3741/4885KDM4E 4815/4885 |
| US-20080262230-A1 | Benzyloxypropylamine Derivative | BDKRB2, BDKRB1, PNMT | HSD17B10 3799/4885L3MBTL1 1221/4885KDM4E 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.